Carlos Gustavo Torres, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 3 | 2023 | 901 | 0.360 |
Why?
|
| Professional-Patient Relations | 1 | 2015 | 726 | 0.350 |
Why?
|
| Gender Identity | 1 | 2015 | 766 | 0.340 |
Why?
|
| Pyridoxal Phosphate | 4 | 2002 | 125 | 0.270 |
Why?
|
| Edetic Acid | 4 | 2002 | 283 | 0.260 |
Why?
|
| Qualitative Research | 1 | 2015 | 3023 | 0.240 |
Why?
|
| Health Personnel | 1 | 2015 | 3335 | 0.200 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 3357 | 0.170 |
Why?
|
| Long QT Syndrome | 2 | 2015 | 467 | 0.160 |
Why?
|
| Manganese | 2 | 1997 | 395 | 0.150 |
Why?
|
| Agrochemicals | 1 | 2014 | 10 | 0.120 |
Why?
|
| Isoflurane | 1 | 2015 | 384 | 0.100 |
Why?
|
| KCNQ1 Potassium Channel | 1 | 2011 | 102 | 0.090 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2011 | 141 | 0.090 |
Why?
|
| Action Potentials | 2 | 2015 | 1834 | 0.090 |
Why?
|
| Anesthetics, Inhalation | 1 | 2015 | 574 | 0.090 |
Why?
|
| Contrast Media | 4 | 2002 | 5311 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 1693 | 0.080 |
Why?
|
| Social Support | 1 | 2015 | 2172 | 0.060 |
Why?
|
| Liver | 2 | 1997 | 7532 | 0.060 |
Why?
|
| Boston | 1 | 2015 | 9330 | 0.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 4014 | 0.050 |
Why?
|
| Communication Barriers | 1 | 2023 | 413 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 2243 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2002 | 36423 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 20093 | 0.040 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 5335 | 0.030 |
Why?
|
| El Salvador | 1 | 2014 | 33 | 0.030 |
Why?
|
| Language | 1 | 2023 | 1539 | 0.030 |
Why?
|
| Europe | 2 | 1997 | 3423 | 0.030 |
Why?
|
| Liver Diseases | 1 | 2002 | 1297 | 0.030 |
Why?
|
| Agriculture | 1 | 2014 | 191 | 0.030 |
Why?
|
| Safety | 1 | 1997 | 1150 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 59207 | 0.020 |
Why?
|
| Caregivers | 1 | 2022 | 2237 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 30045 | 0.020 |
Why?
|
| Adolescent | 2 | 2015 | 88313 | 0.020 |
Why?
|
| Parents | 1 | 2023 | 3564 | 0.020 |
Why?
|
| Humans | 11 | 2023 | 761423 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2014 | 2281 | 0.020 |
Why?
|
| Mental Health | 1 | 2023 | 3249 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2880 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2002 | 20556 | 0.020 |
Why?
|
| Polymers | 1 | 2014 | 1614 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4278 | 0.020 |
Why?
|
| Male | 6 | 2015 | 360736 | 0.020 |
Why?
|
| Female | 6 | 2015 | 392581 | 0.010 |
Why?
|
| Liver Neoplasms | 2 | 1997 | 4320 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8641 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2000 | 5365 | 0.010 |
Why?
|
| Poverty | 1 | 2014 | 2697 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2014 | 5970 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2014 | 4467 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2000 | 58956 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 15605 | 0.010 |
Why?
|
| Middle Aged | 5 | 2014 | 220826 | 0.010 |
Why?
|
| Adult | 5 | 2014 | 221148 | 0.010 |
Why?
|
| Prevalence | 1 | 2014 | 15717 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2014 | 12951 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2002 | 12970 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 3418 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2000 | 2218 | 0.010 |
Why?
|
| Child | 1 | 2023 | 80162 | 0.010 |
Why?
|
| United States | 1 | 2022 | 72339 | 0.010 |
Why?
|
| ROC Curve | 1 | 2002 | 3580 | 0.010 |
Why?
|
| Aged | 4 | 2002 | 169235 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2002 | 2884 | 0.010 |
Why?
|
| Risk Factors | 1 | 2014 | 74167 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14664 | 0.000 |
Why?
|
| Prospective Studies | 2 | 2002 | 54415 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 2000 | 11106 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 8999 | 0.000 |
Why?
|